Changes in biliary excretory mechanisms in rats with ethinyloestradiol-induced cholestasis.
Several excretory pathways for cholephilic compounds have been known. To examine the changes in excretory pathways in cholestasis induced by ethinyloestradiol, various bile acids, organic anions and organic cations were intravenously administered to ethinyloestradiol-treated rats and their biliary excretion was studied. Biliary excretion of taurocholate was slightly delayed, but its excretory maximum was markedly decreased. Biliary excretion of lithocholate-3-O-glucuronide, leukotriene C4, sulphobromophthalein and pravastatin was markedly impaired to a similar extent. Biliary excretion of vinblastine, a P-glycoprotein substrate, was increased, suggesting increased expression of P-glycoprotein. In contrast, biliary excretion of erythromycin, a cationic antibiotic, was markedly impaired. In conclusion, ethinyloestradiol treatment altered the biliary excretion of organic compounds, which may partly be related to changes of the canalicular transporters.
Takikawa
H
H
Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Takamori
Y
Y
Sano
N
N
Kuyama
Y
Y
Yamanaka
M
M
D000818:Animals; D001646:Bile / Q000737:chemistry / Q000378:metabolism*; D001647:Bile Acids and Salts / Q000378:metabolism*; D001692:Biological Transport; D002779:Cholestasis / Q000139:chemically induced / Q000378:metabolism*; D045166:Estradiol Congeners; D004997:Ethinyl Estradiol; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
D001647:Bile Acids and Salts; D045166:Estradiol Congeners; D004997:Ethinyl Estradiol